VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Basher G.

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Mar 25, 2021 6:40pm

193 Views

Post# 32883334

RE:RE:RE:RE:Basher G.

Bihicellow wrote: THE Obvious FACTS is what U don’t like IDI OT , no sales to speak off especially when its in CHINA lol , George is becoming more of BS ER than ever , 10 sales in China in one interview , opps I guess I should do a NR ?? What a crock a brown bananas , we have nothing so far absolutely zero !! Just hype and BS , who wants to buy this thing ? He can mention all the big names he talked to all he wants , talk is really cheap , George is desperate , he invited a DR in this webinar with no name ! KSS , DR WTF is his name ??

Not sure I have seen a surname like that before but there's a first for everything I guess:

BioPub Founder

Founder and Editor-in-Chief - Dr. KSS MD PhD

I am an MD with an additional PhD in biochemistry, and for the past 20 years, in addition to practicing, being a researcher, and conducting clinical trials, have been investing in biotech companies with great success. I earned my degrees at a top 10 US institution, where I was an NIH scholar and graduated with top honors. I have extensive post-doctoral research experience and am board certified in internal medicine and also gastroenterology. My goal is to discuss companies and use discussions of their technology, their drugs or planned drugs, as ways of teaching about physiology and disease states, along with their issues and opportunities.